Edward Erickson, a serial healthcare entrepreneur, has been named a venture partner with SC Capital Partners, the venture capital fund of the Philadelphia-based Science Center. www.sciencecenter.org
Robert McCooey Jr. has been named senior vice president in charge of a new capital markets group at Nasdaq. He previously was president and CEO of NYSE floor broker Grisworld Co. www.nasdaq.com
Mascoma Corp., a Cambridge, Mass.-based company focused on cellulosic biomass-to-ethanol development and production, has raised $30 million in second-round funding. General Catalyst Partners led the deal, and was joined by Kleiner Perkins Caufield & Byers, VantagePoint Venture Partners, Atlas Venture, Pinnacle Ventures and return backers Khosla Ventures and Flagship Ventures. www.mascoma.com
Motorola Inc. (NYSE: MOT) has agreed to acquire Good Technology Inc., a Santa Clara, Calif.
Tony Veith has joined Clearview Capital as a principal. He has spent the past 10 years as a senior vice president in the New York office of LaSalle Business Credit. www.clearviewcap.com
ACA Capital Holdings Inc., a New York-based specialty finance company focused on asset management services and credit protection products, priced 12.2 million common shares at $13 per share ($15-$17 forecast), for an IPO take of approximately $158.6 million. It will trade on the NYSE under ticker symbol ACA, while Credit Suisse, JPMorgan and Bear Stearns […]
Pluck Inc., an Austin, Texas-based provider of social media solutions for online publishers, has raised $7 million in Series B-1 funding. Reuters was joined on the deal by return backers Austin Ventures and Mayfield. It now has raised around $17 million in total VC funding since its 2003 inception. www.pluck.com
Theranos Inc., a Menlo Park, Calif.-based provider of bio-monitoring systems, has secured around $22 million of a $30 million Series C round, according to a regulatory filing. Return backers include ATA Ventures and Draper Fisher Jurvetson. www.theranos.com
Talyst, a Bellevue, Wash.-based provider of automation solutions for central pharmacies, has raised $20 million in Series B funding co-led by Ignition Partners and OVP Venture Partner. The company had closed a $9 million Series A deal in 2005 from AIG Horizon Partners. www.talyst.com
Transcend Medical Inc., a Menlo Park, Calif.-based developer of medical devices to treat glaucoma, has raised $7 million in Series A funding. Backers include Morgenthaler Ventures and Split Rock Partners.